As per MRFR analysis, the US Veterinary Infusion Pumps Market Size was estimated at 21.84 (USD Million) in 2023. The US Veterinary Infusion Pumps Market Industry is expected to grow from 23(USD Million) in 2024 to 36.5 (USD Million) by 2035. The US Veterinary Infusion Pumps Market CAGR (growth rate) is expected to be around 4.288% during the forecast period (2025 - 2035).
In the US Veterinary Infusion Pumps Market, there are several notable trends shaping the landscape. A key market driver is the increasing awareness among pet owners regarding the importance of advanced veterinary care. With the rise in pet ownership in the US, especially in urban areas, more pet owners seek sophisticated treatment options, including infusion therapy for conditions like dehydration and chronic illnesses. This shift is further propelled by the increasing number of veterinary clinics and hospitals that are integrating specialized care, highlighting the growing demand for reliable and efficient infusion pumps.
Opportunities abound in the development of innovative infusion pump technologies. Manufacturers are exploring wireless infusion pumps that enhance the monitoring of medication delivery. Additionally, user-friendly designs that cater to veterinary professionals are emerging, reducing the risk of errors during administration. The push for automated pumps that come with smart features, such as dose calculation and tracking, is also significant, enabling better patient management and care.
Trends in recent times show a rise in the adoption of telemedicine in the veterinary field, particularly post-pandemic. This allows for continuous care and monitoring of pets, leading to increased reliance on infusion pumps, even in remote settings. Furthermore, the collaboration between tech firms and veterinary equipment manufacturers is on the rise, focusing on integrating infusion pumps with digital health solutions to provide seamless patient care. Overall, the US market reflects a growing commitment to enhancing veterinary services through technological advancements and a deeper understanding of animal healthcare needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising trend of pet ownership in the United States significantly drives the US Veterinary Infusion Pumps Market Industry. According to the American Pet Products Association, around 67% of U.S. households, which equates to approximately 85 million families, own a pet as of 2022.
This figure represents a steady increase from previous years. The increasing emotional bonding and the prioritization of pets' health are leading to more frequent veterinary visits, subsequently boosting the demand for advanced veterinary medical equipment, including infusion pumps. Establishments like the American Veterinary Medical Association promote technological advances in veterinary care, thereby influencing the infusion pumps market positively.
The continuous advancements in veterinary technology are propelling the growth of the US Veterinary Infusion Pumps Market Industry. Recent innovations in infusion pump technology, such as enhanced accuracy, ease of use, and remote monitoring capabilities, make these devices more appealing to veterinary practitioners.
For instance, companies like Smiths Medical and Baxter are known for their innovative veterinary infusion devices that meet stringent safety standards and provide precise fluid delivery. These advancements help to support improved patient outcomes, which is critical for veterinary practices aiming for excellence in pet care. Over 30% of veterinarians in the U.S. have reported that technology upgrades have enhanced treatment efficacy, according to surveys conducted by the Veterinary Hospital Managers Association.
The increasing prevalence of chronic diseases in animals, such as diabetes and renal failure, significantly propels the growth of the US Veterinary Infusion Pumps Market Industry. The American Animal Hospital Association reports a 20% rise in chronic illness cases among pets over the last decade, primarily due to better diagnostic capabilities and increased pet longevity.
This trend necessitates the use of infusion therapy, which allows for precise medication and fluid delivery to manage these conditions effectively. As the need for ongoing treatment rises, veterinary facilities are increasingly investing in high-quality infusion pumps to ensure optimal patient care, positively impacting the overall market.
Regulatory frameworks in the United States are increasingly supportive of innovations in veterinary healthcare, boosting the US Veterinary Infusion Pumps Market Industry. The U.S. Food and Drug Administration (FDA) has been active in expediting the approval of new veterinary devices, which facilitates quicker access to advanced therapies for animals.
The FDA Veterinary Innovation Program encourages the development of new technologies while offering guidance and resources to innovators. Recent numbers show that over 200 new veterinary devices were approved in the last three years, reflecting a growing commitment to enhance animal health. This regulatory support encourages manufacturers to invest in developing advanced infusion pumps, thus fostering market growth.
The US Veterinary Infusion Pumps Market is experiencing notable growth within its Type segmentation, which encompasses categories such as Syringe Infusion Pumps and Large-Volume Infusion Pumps. Syringe Infusion Pumps are particularly significant in veterinary practices due to their precision and ability to deliver exact dosages of medication, making them essential for critical care and the management of chronic conditions in animals.
This accuracy ensures that veterinary professionals can provide effective treatment while minimizing the risk of overdose or underdose, a crucial factor in maintaining animal health. On the other hand, Large-Volume Infusion Pumps cater to the higher demand for fluid administration in larger animals or in scenarios requiring substantial medication delivery, highlighting their importance in multi-patient veterinary settings, such as emergency and critical care units.
The growing adoption of these infusion pumps can be attributed to the increase in pet ownership in the US and a rising trend toward advanced veterinary therapies. Reports have shown that the US population's love for pets translates into a heightened demand for innovative veterinary care solutions, thus driving the requirement for efficient infusion technology. Additional factors influencing this market include technological advancements, which are enhancing the features of infusion pumps, and the integration of smart technologies that allow for better tracking and management of infusion therapies. However, challenges such as the high initial cost of these devices and the need for regular maintenance may impact the market growth. Despite these barriers, the expansion of veterinary clinics and hospitals across the US presents opportunities for increased penetration of infusion pumps. The US Veterinary Infusion Pumps Market demonstrates promising potential amidst these dynamics, ensuring a positive outlook for both the Syringe Infusion Pumps and Large-Volume Infusion Pumps segments as they play vital roles in improving patient outcomes in veterinary medicine.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The End User segment of the US Veterinary Infusion Pumps Market is primarily categorized into veterinary hospitals, veterinary clinics, and others, each playing a significant role in the overall market landscape. Veterinary hospitals are crucial as they often provide specialized services and advanced treatments, leading to a higher demand for infusion pumps in emergency and critical care settings.
They typically have greater resources and advanced equipment, thus contributing to a substantial share in the market. Veterinary clinics, on the other hand, serve as primary care facilities, emphasizing routine treatments that also require effective infusion systems to ensure quality care for pets.
The 'Others' category encompasses a variety of end users, including animal research facilities and rehabilitation centers, which are increasingly adopting infusion technology to enhance patient outcomes. The diversification in the End User classification reflects the growing awareness and necessity of advanced veterinary care, paving the way for increased market revenue. Trends indicate a shift towards specialized veterinary services requiring innovative infusion pump technologies, fueling market growth and presenting an array of opportunities for industry players. Understanding these dynamics is essential as they demonstrate how the US Veterinary Infusion Pumps Market is evolving to meet the needs of diverse end users in veterinary healthcare.
The US Veterinary Infusion Pumps Market is characterized by a dynamic landscape where innovation and technological advancements play a pivotal role in shaping competitive strategies among key players. This market primarily serves the increasing demand for precise and effective infusion therapies in veterinary practices, catering to both small and large animals.
Companies in this sector strive to enhance their product offerings by focusing on reliability, ease of use, and integration with existing veterinary workflows. As the need for specialized veterinary care grows, manufacturers are compelled to leverage their strengths to differentiate their products, form strategic partnerships, and expand their market presence. The competition is fierce, driven by the necessity to meet regulatory standards and the evolving expectations of veterinary professionals and pet owners alike.
Scivita Medical has carved a notable niche within the US Veterinary Infusion Pumps Market with its innovative infusion solutions tailored specifically for veterinary applications. The company is recognized for its commitment to quality and performance, providing infusion pumps that are user-friendly and designed with the specific needs of veterinarians in mind.
The strengths of Scivita Medical lie in its advanced engineering capabilities, which allow for the development of specialized products that enhance the veterinary care experience. Their continuous focus on research and development also positions them favorably in the competitive landscape, ensuring they remain at the forefront of technology within this specialized market.
Smiths Medical holds a significant presence in the US Veterinary Infusion Pumps Market, recognized for its robust portfolio of infusion devices and related services. The company offers a range of key products, including safety infusion pumps that are critical in veterinary settings.
Smiths Medical’s strengths stem from its extensive experience in the medical device industry, allowing it to bring high-quality technology into the veterinary domain. The company has successfully implemented mergers and acquisitions to bolster its market position, acquiring innovative companies that enhance its product line and expand its capabilities. With a strong focus on improving patient outcomes, Smiths Medical continues to evolve and adapt its offerings to meet the demands of veterinarians across the United States. Their comprehensive support services and commitment to customer satisfaction further reinforce their competitive edge in the market.
In recent months, the US Veterinary Infusion Pumps Market has shown significant activity. Notable developments include advancements in technology moving towards more automated and precise infusion systems. Companies like Smiths Medical and Medtronic are focusing on enhanced user interfaces and data management capabilities for their infusion systems.
Additionally, the impacts of the COVID-19 pandemic have prompted an increased emphasis on veterinary care, leading to greater demand for infusion pumps in veterinary practices and clinics. In terms of mergers and acquisitions, July 2023 saw Zoetis acquire Abaxis, further consolidating their position in the veterinary diagnostics market, which can indirectly influence products such as infusion pumps.
The overall market valuation is expected to grow, driven by the rising prevalence of chronic diseases in pets, thereby increasing the demand for infusion therapies. The competition among established players such as Nihon Kohden and B. Braun Melsungen AG continues to intensify as they aim to expand their product offerings and reach more veterinary facilities in the US. Over the past two years, veterinary practices have increasingly sought more integrated and comprehensive solutions for patient management, further bolstering the market for infusion systems.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 21.84(USD Million) |
| MARKET SIZE 2024 | 23.0(USD Million) |
| MARKET SIZE 2035 | 36.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.288% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Scivita Medical, Smiths Medical, Jorvet, Abaxis, Caresyntax, Vetland Medical, Medtronic, Zoetis, Sunking, Baxter International, DRE Veterinary, Nihon Kohden, Heska Corporation, Mindray, B. Braun Melsungen AG |
| SEGMENTS COVERED | Type, End User |
| KEY MARKET OPPORTUNITIES | Growing pet healthcare awareness, Advancements in pump technology, Increasing veterinary practice standards, Rising demand for home care, Expansion in specialty veterinary clinics |
| KEY MARKET DYNAMICS | rising pet adoption rates, technological advancements, increasing veterinary care costs, growing awareness of animal health, regulatory approvals and compliance |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Veterinary Infusion Pumps Market is expected to be valued at 23.0 million USD in 2024.
The expected compound annual growth rate (CAGR) for the US Veterinary Infusion Pumps Market from 2025 to 2035 is 4.288%.
The market is anticipated to reach a value of 36.5 million USD by 2035.
The Syringe Infusion Pump segment is valued at 10.0 million USD in 2024 and is projected to grow to 16.2 million USD by 2035.
The Large-Volume Infusion Pump segment is valued at 13.0 million USD in 2024 and is expected to increase to 20.3 million USD by 2035.
Major players in the market include Scivita Medical, Smiths Medical, Jorvet, Abaxis, and Medtronic.
Key opportunities lie in advancements in infusion pump technology and the growing demand for veterinary healthcare.
Challenges include regulatory hurdles and the need for significant investment in innovation and research.
The US Veterinary Infusion Pumps Market is expected to maintain a steady growth rate compared to other regional markets over the forecast period.
Key applications include critical care, surgery, and fluid therapy in various veterinary practices.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
